Filing Details

Accession Number:
0001209191-20-003092
Form Type:
4
Zero Holdings:
No
Publication Time:
2020-01-10 17:28:32
Reporting Period:
2020-01-09
Accepted Time:
2020-01-10 17:28:32
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1178879 Amicus Therapeutics Inc. FOLD Pharmaceutical Preparations (2834) 200422823
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1400971 L Bradley Campbell C/O Amicus Therapeutics, Inc.
1 Cedar Brook Drive
Cranbury NJ 08512
Chief Operating Officer Yes Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2020-01-09 2,500 $5.96 347,695 No 4 M Direct
Common Stock Disposition 2020-01-09 2,500 $10.01 345,195 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Options (right to buy) Disposition 2020-01-09 2,500 $0.00 2,500 $5.96
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
20,000 2021-01-19 No 4 M Direct
Footnotes
  1. The exercise of stock options and subsequent sale of common stock were made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.
  2. All of the options were fully vested and exercisable as of January 9, 2020.